Evidence map›Paper›PMID 25980759›Full record

ArticleRetrovirology2015

Single amino acid substitution (G42E) in the receptor binding domain of mouse mammary tumour virus envelope protein facilitates infection of non-murine cells in a transferrin receptor 1-independent manner.

Constantine James Konstantoulas, Benjamin Lamp, Tillman Hans Rumenapf, Stanislav Indik

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Mouse Mammary Tumor Virus (MMTV)-LikeInternational journal of environmental research and public health · 2020
    Article
  10. Article
  11. Article
  12. Retroviral host range extension is coupled with Env-activating mutations resulting in receptor-independent entry.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  13. Evolutionary ecology of virus emergence.Annals of the New York Academy of Sciences · 2017
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Constantine James KonstantoulasInstitute of Virology, University of Veterinary Medicine, Veterinaerplatz 1, 1210, Vienna, Austria. Constantine.Konstantoulas@vetmeduni.ac.at.
Benjamin LampInstitute of Virology, University of Veterinary Medicine, Veterinaerplatz 1, 1210, Vienna, Austria. benjamin.lamp@vetmeduni.ac.at.
Tillman Hans RumenapfInstitute of Virology, University of Veterinary Medicine, Veterinaerplatz 1, 1210, Vienna, Austria. Till.Ruemenapf@vetmeduni.ac.at.
Stanislav IndikInstitute of Virology, University of Veterinary Medicine, Veterinaerplatz 1, 1210, Vienna, Austria. Stanislav.Indik@vetmeduni.ac.at.
University of Veterinary Medicine Vienna · AT

Funding

Austrian Science Fund FWF P 21494
6 · The paper itself

Abstract

backgroundMouse mammary tumour virus (MMTV) is a betaretrovirus that infects rodent cells and uses mouse tranferrin receptor 1 (TfR1) for cell entry. Several MMTV strains have been shown to productively infect, in addition to murine cells, various heterologous cell lines including those of human origin, albeit less efficiently than murine cells. Furthermore, there have been reports that the continued passage of MMTV in heterologous cell lines gives rise to novel variants that are able to infect naive non-murine cells with higher efficiency than the parental virus.

resultsWe show that MMTV(C3H), like other MMTV strains, that had undergone a number of replication cycles in non-murine cells displayed an increased replication kinetic, as compared to parental virus, when applied on naive human cells. Sequence analysis of several replication kinetic variants and the parental virus, together with calculation of the ratio of non-synonymous to synonymous mutations at individual codons, revealed that several regions within the viral genome were under strong positive selection pressure during viral replication in human cells. The mutation responsible, at least in part, for the phenotypic change was subsequently mapped to the segment of env encoding the receptor binding site (F₄₀HGFR₄₄). Introduction of the identified mutation, leading to single amino acid substitution (G42E), into egfp-containing recombinant MMTV virions enhanced their ability to bind to and infect human cells. Interestingly, neither the replication kinetic mutant nor the parental virus required human TfR1 for infection. Knock-out of TFR1 gene from the human genome did not decrease the susceptibility of Hs578T cells to virus infection. Furthermore, the expression of human TfR1, in contrast to mouse TfR1, did not enhance the susceptibility of MMTV-resistant Chinese hamster ovary cells. Thus, human TfR1 is dispensable for infection and another cell surface molecule mediates the MMTV entry into human cells.

conclusionTaken together, our data explain the mechanism enabling MMTV to form 'host-range variants' in non-murine cells that has been known for a long time, the basis of which remained obscure. Our findings may expand our understanding of how viruses gain capability to cross species-specific barriers to infect new hosts.

Indexed as

Host SpecificityMutation, MissenseVirus InternalizationAmino Acid SubstitutionAnimalsCell LineHumansMammary Tumor Virus, MouseMutant ProteinsReceptors, TransferrinSerial PassageViral Envelope ProteinsVirus ReplicationMutant ProteinsReceptors, TransferrinViral Envelope Proteins

Identifiers

PMID25980759
PMCPMC4445801
OpenAlexW2132930513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.